Transitional Tissue Changes
Across the Health Spectrum.
From Dead/Calcium,
to Normal Healthy Tissue,
to InflammoThrombotic Immunologic Responses
to Ultimately Becoming Cancer
Every organ in your body has a function. The heart is responsible for pumping blood with nutrients around the body. The lungs are responsible for bringing oxygen into the body and removing carbon dioxide - an acid - from the body. The breasts are responsible for producing milk for infant nutrition.
​
These organs are composed of specialized cells. Each with the same genetic material as any other cell in the body, yet each uniquely serving a function required for that organ to work and keep the body alive and hopefully healthy.
​
For a variety of reasons including; but not limited to, people being exposed to chemicals (carcinogens) that can damage this genetic material; changes in the DNA can occur, allowing healthy cells to become unhealthy. These unhealthy changes can be measured using FMTVDM as the InflammoThrombotic Immunologic Response (ITIR) becomes unhealthy, which we call Disease (ITIRD).
​
I frequently explain this to my students by telling them cancers are a lot like teenagers, or perhaps medical students. They eat a lot and aren't known for doing very much.
​
The following video is another way to think of the InflammoThrombotic Immunologic Response Disease (ITIRD) we call cancer and the changes in tissue that lead up to cancer.
In some people this genetic material - deoxyribonucleic acid or DNA - is more susceptible to damage and errors than that of other people.
As I explained during the COVID pandemic [https://www.flemingmethod.com/answers] as shown in the diagram that follows, there a variety of factors can produce changes within cells which can ultimately result in cancer.
Independent of the cause, under the wrong circumstances, these normally functioning healthy cells become damaged, responding to that damage sometimes in unfavorable ways, disrupting homeostasis.
During the body's attempt at homeostasis - the body's attempt to maintain a stable environment inside the body despite external factors - there is an InflammoThrombotic Immunologic Response (ITIR) including the release of chemical messengers by the cells asking the immune system for help - to kill the cancer.
If this ITIR is successful, a response frequently associated with the activation of Natural Killer (NK) Cells, the the damaged cells are removed and health is restored. It is estimated that this occurs at least once a day, every day, for the average individual.
​
The following video shows an activated NK cell attacking a cancer cell.
If however, the cancer cell - or more correctly the cell undergoing transitional changes, which will left unchecked by the ITIR, become a cancer cell.
Within these cells, certain genes within the mitochondria (cell powerhouse) of the cells become activated, as the metabolic demands of the tissue (cells) changes.
This increase in metabolic activity of the cell, along with the production of other chemical messengers responsible for increasing regional blood flow to the tissue, results in measurable tissue changes in regional blood flow and metabolism; changes which are measured by FMTVDM.
​
This change in tissue metabolism and blood flow can be targeted to treat cancer patients and help restore homeostasis and health.
The following figure shows just some of the chemical processes that occur inside the mitochondria of a cell undergoing these transitional changes.
The following slide shows just a few of the ITIR chemicals, released in response to these cellular changes. When added together, the end result is an increase in regional metabolic and blood flow activity.
The white arrows point to small blood vessels (capillaries) growing between cells in response to the release of one of the ITIR chemical messengers, CD34.
The changes resulting from increased metabolic activity and consequential increased cellular density resulting from the increase in cellular mitotic (division) activity, along with the increased regional blood flow, may not be fully appreciated when looking at only one area of tissue, or when looking for change at one point in time; but, this transitional change becomes more obvious when comparing changes in tissue over time as measured by FMTVDM and as seen in the next set of microscopy slides.
​
Changes in tissue can be seen in this sequence of pathology slides going from A to D, where the blue stained areas are the nuclei of cells with the DNA and the brown stained material are the blood vessels. As cancer develops (A -> D), you can clearly see an increase in both the number and density of cells shown by the blue staining as well as an increase in the regional blood supply shown by the brown staining.
It is this ever increasing change in regional metabolic and blood flow changes that allow FMTVDM to measure changes in tissue as tissue becomes less health, or healthier - including the ability to measure the impact of treatments.